A study led by center member Dr. Fred Korley, associate professor of Emergency Medicine at the University of Michigan Medical School, found that blood tests taken the day of a traumatic brain injury can predict which patients are likely to die or survive with severe disability, allowing clinicians to make decisions earlier on possible treatment of TBI.

Results published in The Lancet Neurology reveal that higher values of two protein biomarkers, GFAP and UCH-L1, are associated with death and severe injury. According to Korley, this is the first study to examine the association between GFAP and UCH-L1 biomarker levels and all-cause mortality following TBI.

Learn more here.